Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meningococcal and Pneumococcal Immunization in HIV Adults
NCT04875819Phase 4Recruiting
- Start
- Apr 2021
- Primary completion
- Dec 2026
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of meningococcal A conjugate vaccine, meningococcal group B vaccine, pneumococcal 13-valent conjugate vaccine, 23-valent pneumococcal polysaccharide vaccine in meningococcal infection, pneumococcal infection. Started Apr 2021; status: recruiting.
02
Drugs
meningococcal A conjugate vaccinemeningococcal group B vaccinepneumococcal 13-valent conjugate vaccine23-valent pneumococcal polysaccharide vaccine
03
Conditions
meningococcal infectionpneumococcal infection
Beyond the preview
Go deeper on NCT04875819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04875819.